Bio-Technology General regulatory update

BTGC (Iselin, NJ) submitted an NDA to the FDA for Hepandrin (oxandrolone) to treat alcoholic hepatitis. The submission was based on

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.